We are live on ! Find out more
PCA

Providence Capital Advisors Portfolio holdings

AUM $613M
1-Year Est. Return 17.83%
This Fund
S&P 500
This Quarter Est. Return
-0.97%
1 Year Est. Return
+17.83%
3 Year Est. Return
+42.1%
5 Year Est. Return
+50.05%
10 Year Est. Return
AUM
$321M
AUM Growth
+$11.5M
Cap. Flow
+$16.1M
Cap. Flow %
5.01%
Top 10 Hldgs %
26.2%
Holding
358
New
36
Increased
93
Reduced
39
Closed
39

Top Buys

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$4.11M
2
GLW icon
Corning
GLW
+$4.02M
3
BAX icon
Baxter International
BAX
+$3.78M
4
BSX icon
Boston Scientific
BSX
+$3.65M
5
CSX icon
CSX Corp
CSX
+$3.5M

Sector Composition

Rank Sector Weight
1 Technology 22.33%
2 Healthcare 13.54%
3 Financials 12.68%
4 Communication Services 10.01%
5 Consumer Staples 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVGO icon
51
Broadcom
AVGO
$1.85T
$2.5M 0.78%
51,650
+4,660
+10% +$227K
CSCO icon
52
Cisco
CSCO
$457B
$2.49M 0.77%
45,679
+4,162
+10% +$234K
CCI icon
53
Crown Castle
CCI
$33.3B
$2.41M 0.75%
13,879
+1,165
+9% +$225K
ABBV icon
54
AbbVie
ABBV
$443B
$2.4M 0.75%
22,289
+7,075
+47% +$808K
VLO icon
55
Valero Energy
VLO
$90.1B
$2.38M 0.74%
33,794
+3,076
+10% +$205K
UL icon
56
Unilever
UL
$137B
$2.17M 0.68%
35,651
+3,262
+10% +$208K
D icon
57
Dominion Energy
D
$60.8B
$2.15M 0.67%
29,470
+2,683
+10% +$205K
KEY icon
58
KeyCorp
KEY
$24.2B
$2.12M 0.66%
98,076
+31,084
+46% +$628K
GIS icon
59
General Mills
GIS
$19.1B
$2.1M 0.65%
35,042
+3,129
+10% +$185K
HR
60
DELISTED
Healthcare Realty Trust Incorporated
HR
$2.06M 0.64%
69,117
+6,376
+10% +$195K
CVX icon
61
Chevron
CVX
$392B
$2M 0.62%
19,719
+1,608
+9% +$160K
SNY icon
62
Sanofi
SNY
$103B
$2M 0.62%
41,495
+3,830
+10% +$195K
MMM icon
63
3M
MMM
$90.9B
$1.93M 0.6%
13,136
+1,133
+9% +$184K
T icon
64
AT&T
T
$159B
$1.92M 0.6%
94,200
+8,210
+10% +$172K
HYG icon
65
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$1.86M 0.58%
21,247
+1,825
+9% +$160K
KO icon
66
Coca-Cola
KO
$377B
$1.86M 0.58%
35,365
+1,102
+3% +$61.4K
USB icon
67
US Bancorp
USB
$98.2B
$1.79M 0.56%
30,182
+2,686
+10% +$153K
BMY icon
68
Bristol-Myers Squibb
BMY
$133B
$1.79M 0.56%
30,184
+2,142
+8% +$141K
EMB icon
69
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
$1.78M 0.56%
16,213
+1,506
+10% +$169K
IJH icon
70
iShares Core S&P Mid-Cap ETF
IJH
$122B
$1.78M 0.55%
33,795
-1,555
-4% -$83.7K
AEP icon
71
American Electric Power
AEP
$69.6B
$1.74M 0.54%
21,406
+1,968
+10% +$172K
AMD icon
72
Advanced Micro Devices
AMD
$776B
$1.66M 0.52%
16,115
-5,992
-27% -$613K
KMB icon
73
Kimberly-Clark
KMB
$36.3B
$1.66M 0.52%
12,499
+1,120
+10% +$152K
NVS icon
74
Novartis
NVS
$297B
$1.65M 0.51%
20,149
+1,857
+10% +$167K
BCE icon
75
BCE
BCE
$20.2B
$1.62M 0.5%
32,296
+2,984
+10% +$151K

Similar funds

Providence Capital Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Providence Capital Advisors held 358 positions worth $321M, up 3.7% from $309M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Providence Capital Advisors deployed $16.1M of net new capital in Q3 2021, opening 36 new positions and adding to 93 existing holdings. Its largest new stake was Boston Scientific: 82,600 shares worth $3.58M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Gilead Sciences, an estimated $4.44M trimmed.

  • Providence Capital Advisors's largest Q3 2021 buy was Boston Scientific: 82,600 shares worth $3.58M.
  • Providence Capital Advisors added most to Starbucks in Q3 2021, an estimated $4.11M increase.
  • Providence Capital Advisors's biggest Q3 2021 reduction was Gilead Sciences, cutting an estimated $4.44M.
  • Providence Capital Advisors fully exited Johnson Controls International in Q3 2021, selling an estimated $3.69M.
  • Providence Capital Advisors's ten largest holdings make up 26% of its $321M portfolio in Q3 2021.
  • Providence Capital Advisors opened 36 new positions and closed 39 in Q3 2021.
  • Providence Capital Advisors's portfolio value rose 3.7% quarter-over-quarter to $321M.

Based on Providence Capital Advisors's 13F filing for Q3 2021, filed 9 Nov 2021.